Apriem Advisors Amarin Corp Plcuk Transaction History

Apriem Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $179,692 - $318,202	-14,250 Closed	0 $0
Q4 2018 Feb 19, 2019	BUY	$12.41 - $22.98 $176,842 - $327,465	14,250 New	14,250 $194,000
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $18,664 - $123,944	-7,618 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.68 - $3.48 $20,416 - $26,510	7,618 New	7,618 $24,000

187

77.1M

247K

121K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Apriem Advisors, based on Form 13F filings with the SEC.

Stay updated on Apriem Advisors with notifications on news.